The silicon microneedle Company

Intradermal (ID) monkeypox vaccination approved in US and EU
(
fda.gov or ema.com)

U-Needle congratulates its CEO Jeroen Wissink with winning the Van den Kroonenberg award 2022!


U-Needle enables easy and reliable injection and infusion into superficial tissues.

We achieve this by designing and manufacturing easy-to-use, patient friendly silicon microneedles which are very sharp and precise. Our proprietary technology makes use of innovative manufacturing processes and needle designs. Furthermore U-Needle is full scope ISO 13485 certified.

Bella-mu | the intradermic needle is our first CE certified and FDA approved product range and is well received by clinicians.

We focus on intradermal and suprachoroidal delivery and, together with our B2B customers, we aim to provide the market with improved therapies enable by our silicon microneedle.

Routes of administration

Our vision

Microneedle injection technology will unlock the potential of precise, superficial drug delivery - such as intradermal and suprachoroidal - enabling improved therapies.